Iterum Therapeutics (ITRM) Q1 2026 Earnings

Mar 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.2
-0.16
-0.13
-0.09

Details

Expected EPS
-0.145
Actual EPS
-0.2
Surprise EPS
-0.06
Surprise Percent
-37.93%

Description

⁨Iterum Therapeutics⁩ (⁦ITRM⁩) has reported earnings of ⁦-0.2⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts